Metabolite profiling

In the November Nature Biotechnology Fiehn et al. offer an alternative to the profiling of messenger RNA and protein levels. They use gas chromatography coupled to mass spectrometry (GC/MS) to assay the relative levels of 326 small compounds from a plant leaf extract (Nat Biotech 2000, 18:1157-1161). A simple methanol extraction is followed by derivitization to increase metabolite stability and volatility. Approximately half of the chromatographed compounds can be identified based on retention t

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the November Nature Biotechnology Fiehn et al. offer an alternative to the profiling of messenger RNA and protein levels. They use gas chromatography coupled to mass spectrometry (GC/MS) to assay the relative levels of 326 small compounds from a plant leaf extract (Nat Biotech 2000, 18:1157-1161). A simple methanol extraction is followed by derivitization to increase metabolite stability and volatility. Approximately half of the chromatographed compounds can be identified based on retention times and mass spectra; these results can be viewed on the accompanying website. Biological variability (of approximately 40%) is in clear excess of variability inherent to the method (about 8%). Principal component analysis allows metabolite profiles from plants of a particular genetic background or with a particular mutation to be clustered. Mutation of a single gene causes many changes, most of them unexplained. Metabolite profiles may be useful to address public concerns about the safety of genetically ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies